Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
5.66
|
5.61
|
5.76
|
5.74
|
|
|
44 621 287.00
|
|
|
|
5.76
|
5.66
|
5.88
|
5.68
|
|
|
58 027 115.00
|
|
|
|
5.95
|
5.82
|
5.96
|
5.86
|
|
|
40 390 988.00
|
|
|
|
5.93
|
5.92
|
6.07
|
5.93
|
|
|
60 447 131.00
|
|
|
|
6.30
|
5.93
|
6.48
|
5.96
|
|
|
100 417 513.00
|
|
|
|
6.60
|
6.20
|
6.65
|
6.20
|
|
|
157 068 807.00
|
|
|
|
6.80
|
6.49
|
6.97
|
6.69
|
|
|
257 088 338.00
|
|
|
|
6.59
|
6.40
|
7.33
|
7.14
|
|
|
283 582 441.00
|
|
|
|
6.27
|
6.14
|
6.32
|
6.25
|
|
|
58 957 151.00
|
|
|
|
6.19
|
6.13
|
6.36
|
6.26
|
|
|
90 733 304.00
|
|
ObioTechnology (Shanghai) Corp., Ltd. operates as a biopharmaceutical company. The Company offers holistic CDMO services across plasmid, adeno-associated virus, lentivirus, adenovirus, oncolytic viruses, and cell therapy products for scientists, research facilities, and medical institutions. ObioTechnology (Shanghai) conducts businesses globally.